DSM’s new coating provides an osteoconductive scaffold at the point of repair, unlike other osteoconductive coatings. It has both patents granted and patents pending.
“This is a major step for Riverpoint in providing superior solutions and rapidly innovating high-quality medical devices to improve patient outcomes. Our exclusive OC coating technology is a first of its kind in the field of bone fixation and healing,” Doug King, CEO of Riverpoint Medical, said in a March 7 press release.
